Healthcare -
Biotechnology - NASDAQ - US
$ 34.68
0.405 %
$ 1.98 B
Market Cap
2.97
P/E
Price Target
Average
51.86%
Revenue Forecast
Estimate
198.72%
EBIT
Estimate
--3.10%
Net Income
Estimate
30.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Agios Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for AGIO of $52.7 , with forecasts ranging from
a
low of
$45 to a high of $56 .
AGIO Lowest Price Target
Wall Street Target
45 USD
29.76%
AGIO Average Price Target
Wall Street Target
52.7 USD
51.86%
AGIO Highest Price Target
Wall Street Target
56 USD
61.48%
REVENUE FORECAST
Revenue Forecast Chart AGIO
EBIT FORECAST
EBIT Forecast Chart AGIO
NET INCOME FORECAST
Net Income Chart AGIO